Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Degenerative Spondylolisthesis Treatment--When Surgery Reduces Risks
• Rheumatoid Arthritis and Brain Function
• Music Therapy for Sickle Cell Patients: An Alternative Pain Management
• NIH, HEAL, and Combating the Opioid Crisis
• Nudging for Better Prescribing Practices
• Opioid Prescribing: Sometimes Less May Help More
• Cannabis and the Endocannabinoid System
• A Cost-Effective Intervention for Opioid Misuse?
• Osteolysis Risk: Predicting Bone Loss After Hip Replacement Surgery
• Turn Up the Voltage to Relieve Dry Eye Pain?